Salarius Pharmaceuticals (SLRX) Stock Price
$1.34 0%
to add to portfolio
AI Score
-
Alternative
9 -
Fundamental
2 -
Technical
3
Our AI score evaluates a company's performance on a scale from 0 to 10 by analyzing alternative data points — web traffic, app downloads, job postings, etc - along with financial health and technical signals. Scores below 4 project bearish performance, while scores above 6 project bullish performance.
Sign up to get access to more historical data and insights on Salarius Pharmaceuticals, AI stock picks, stock alerts and much more.
SLRX AI Stock Analysis
AI stock analysis for SLRX is missing at the moment.
Our AI stock analysis reviews financial data, technical analysis, and alternative data insights to project stock performance. For example, analyzing a company like Salarius Pharmaceuticals (SLRX) provides a clear summary of future projections. Gain the edge you need to make confident, data-driven investment decisions.
Sign up and become a member to get access to AI stock analysis.
Sign up
Salarius Pharmaceuticals (SLRX) Price Prediction
Based on a combination of financial analysis, technical indicators, and insights from alternative data, we predict that the stock price of Salarius Pharmaceuticals (SLRX), currently trading at $1.34, will... Sign up to access price prediction.
Disclaimer:
This prediction is provided for informational purposes only and does not constitute financial advice. Market conditions are subject to change, and past performance is not indicative of future results. Please conduct your own research or consult a professional before making investment decisions.
About SLRX
-
Salarius Pharmaceuticals, Inc.
-
Symbol
SLRX
-
Market
NASDAQ
-
Industry
Biotechnology
-
Market Cap
2.1M
Similar Stocks
 |
Catalyst Pharmaceuticals CPRX |
$21.62 2% |
6 |
 |
Inovio Pharmaceuticals INO |
$2.24 0.9% |
2 |
 |
Moderna MRNA |
$35.53 5.3% |
4 |
 |
Anavex Life Sciences AVXL |
$8.35 3.8% |
6 |
 |
BridgeBio Pharma BBIO |
$36.85 0.1% |
6 |
News
SLRX Alternative Data
Web Traffic
Salarius Pharmaceuticals receives an estimated 6799 monthly visitors to salariuspharma.com.
-
Web Traffic
6799
-
Change from Previous Month
1202.5%
-
3 Month Change
620.2%
News Mentions
Salarius Pharmaceuticals was mentioned 0 times in the news yesterday.
-
News Mentions
0
-
Daily Change
0%
-
1 Month Change
0%
-
3 Month Change
0%
Reddit Mentions
Salarius Pharmaceuticals has been mentioned an estimated 0 times in investment subreddits on Reddit over the last 24 hours.
-
Reddit Mentions
0
-
Daily Change
0%
LinkedIn Followers
2,627 are following Salarius Pharmaceuticals on LinkedIn, up by 2.1% over the last month.
-
LinkedIn Followers
2627
-
Daily Change
0%
-
1 Month Change
2.1%
-
3 Month Change
6%
Job Postings
Salarius Pharmaceuticals currenly has an estimated 0 open job postings.
-
Job Postings
0
-
Daily Change
0%
-
1 Month Change
0%
-
3 Month Change
0%
LinkedIn Employees
According to LinkedIn, Salarius Pharmaceuticals has 12 employees.
-
LinkedIn Employees
12
-
Daily Change
0%
-
1 Month Change
0%
-
3 Month Change
0%
Business Outlook
-
Business Outlook
100
-
Change from Previous Month
0%
-
3 Month Change
0%
-
YoY Change
0%
SLRX Financials
SLRX Key Metrics
-
Total Revenue
$0
-
Net Income
-$972.1K
-
Earnings per Share
-$0.76
-
Free cash flow
-$1.4M
-
EBITDA
-$1M
-
EBITDA Ratio
0
-
Total Assets
$3.9M
SLRX 2-year Revenue & Income
SLRX 2-year Free Cash Flow
SLRX Technicals
SLRX SMA
SLRX RSI
FAQ
What's the current price of Salarius Pharmaceuticals (SLRX) Stock?
The price of an Salarius Pharmaceuticals (SLRX) share is $1.34.
What's the market cap of Salarius Pharmaceuticals?
The current market cap of Salarius Pharmaceuticals is 2.1M.
Should I buy or sell SLRX?
Salarius Pharmaceuticals shows several positive indicators, but they aren’t strong enough to warrant a buy recommendation. At its current price, Salarius Pharmaceuticals is better viewed as a hold or accumulate position while waiting for further developments.
Is Salarius Pharmaceuticals a good investment?
The current analysis of Salarius Pharmaceuticals' fundamentals, technical aspects, and alternative data insights indicates a neutral outlook on the stock. While there are promising elements in Salarius Pharmaceuticals' portfolio, the presence of equal risks and opportunities suggests that it might not drive significant gains or losses at this moment.
Is now a good time to buy Salarius Pharmaceuticals (SLRX) Stock?
Based on an analysis that includes fundamentals, technical analysis, and alternative data insights, the outlook for Salarius Pharmaceuticals stock is currently neutral, suggesting a cautious approach might be wise.
What are some stocks similar to Salarius Pharmaceuticals (SLRX) that investors often compare it to?
Salarius Pharmaceuticals (SLRX) is often compared to similar stocks such as Catalyst Pharmaceuticals, Inovio Pharmaceuticals, Moderna, Anavex Life Sciences and BridgeBio Pharma.
What is the forecast for Salarius Pharmaceuticals' stock price in 2026?
Using a mix of financial analysis, technical indicators, and alternative data, we forecast Salarius Pharmaceuticals' stock price to be around $1.3 in 2026. Starting from the current price of $1.34, this represents a 2.8% change in price, indicating a neutral outlook for the stock.
How to buy Salarius Pharmaceuticals (SLRX) Stock?
Salarius Pharmaceuticals stock is available for purchase through numerous brokerage firms, including online platforms. Investors can also buy Salarius Pharmaceuticals shares via trading apps on their smartphones or by utilizing services like robo-advisors for automated investing.